PCSK9 and atherosclerosis: The aim of the research is to evaluate the present state of knowledge, research and development trends in proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in conjunction with the treatment of atherosclerosis and collect bibliometric and scientometric studies of the domain through scientometric analysis.